Milestones

1. National coordinators of the European project MORPHEUS-101095698 "Prognosis improvement of unprovoked venous thromboemlism using personalized anticoagulant therapy".
2. Incorporation of 3 new clinical investigators in the research group. 
3. Participation in the Spanish multicenter study METASLEEP (PMP22/00030), "Impact of the Management of Respiratory Disorders During Sleep on the control of systemic hypertension" funded by the ISCIII. 
4. Co-author of the article: Talasaz AH, Sadeghipour P, Ortega L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jiménez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. NAT REV CARDIOL. 2024;21(8): 574 - 592. DOI:10.1038/ s41569-024-01003-3.
5. Co-author of the most cited article in the journal JACC in 2024: Bejjani A, Khairani CD, Assi A, Piazza G, Sadeghipour P, Talasaz AH, Fanikos J, Connors JM, Siegal DM, Barnes GD, Martin KA, Angiolillo DJ, Kleindorfer D, Monreal M, Jiménez D, Middeldorp S, Elkind MSV, Ruff CT, Goldhaber SZ, Krumholz HM, Mehran R, Cushman M, Eikelboom JW, Lip GYH, Weitz JI, Lopes RD, Bikdeli B. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024;83(3): 444 - 465. DOI:10.1016/j.jacc.2023.10.038.